Institution
Utrecht University
Education•Utrecht, Utrecht, Netherlands•
About: Utrecht University is a education organization based out in Utrecht, Utrecht, Netherlands. It is known for research contribution in the topics: Population & Poison control. The organization has 58176 authors who have published 139351 publications receiving 6214282 citations. The organization is also known as: UU & Universiteit Utrecht.
Papers published on a yearly basis
Papers
More filters
••
Harvard University1, University of Michigan2, VU University Amsterdam3, Boston University4, Katholieke Universiteit Leuven5, University of California, Davis6, University of São Paulo7, Universidade Nova de Lisboa8, University College Hospital, Ibadan9, University of Barcelona10, University of Balamand11, Wrocław Medical University12, EHESP13, The Chinese University of Hong Kong14, Park Centre for Mental Health15, Ulster University16, University of Otago17, Utrecht University18, Center for Excellence in Education19
TL;DR: Mental disorders are common among college students, have onsets that mostly occur prior to college entry, and in the case of pre-matriculation disorders are associated with college attrition, and are typically untreated.
Abstract: Background Although mental disorders are significant predictors of educational attainment throughout the entire educational career, most research on mental disorders among students has focused on the primary and secondary school years. Method The World Health Organization World Mental Health Surveys were used to examine the associations of mental disorders with college entry and attrition by comparing college students (n = 1572) and non-students in the same age range (18–22 years; n = 4178), including non-students who recently left college without graduating (n = 702) based on surveys in 21 countries (four low/lower-middle income, five upper-middle-income, one lower-middle or upper-middle at the times of two different surveys, and 11 high income). Lifetime and 12-month prevalence and age-of-onset of DSM-IV anxiety, mood, behavioral and substance disorders were assessed with the Composite International Diagnostic Interview (CIDI). Results One-fifth (20.3%) of college students had 12-month DSM-IV/CIDI disorders; 83.1% of these cases had pre-matriculation onsets. Disorders with pre-matriculation onsets were more important than those with post-matriculation onsets in predicting subsequent college attrition, with substance disorders and, among women, major depression the most important such disorders. Only 16.4% of students with 12-month disorders received any 12-month healthcare treatment for their mental disorders. Conclusions Mental disorders are common among college students, have onsets that mostly occur prior to college entry, in the case of pre-matriculation disorders are associated with college attrition, and are typically untreated. Detection and effective treatment of these disorders early in the college career might reduce attrition and improve educational and psychosocial functioning.
674 citations
••
TL;DR: The intracellular distribution of MHC class I and class II molecules reflects the dichotomy in presentation of antigen from endogenous and exogenous origin, respectively.
Abstract: Traffic of MHC molecules dictates the source of peptides that are presented to T cells. The intracellular distribution of MHC class I and class II molecules reflects the dichotomy in presentation of antigen from endogenous and exogenous origin, respectively. In human B lymphoblastoid cells, class I molecules are present in compartments constituting the biosynthetic pathway, whereas class II molecules enter structures related to lysosomes during their biosynthesis.
674 citations
••
TL;DR: In this paper, the authors explored the range of future world potential of biomass for energy and focused on the factors that influence the potential biomass availability for energy purposes rather than give exact numbers.
Abstract: This study explores the range of future world potential of biomass for energy. The focus has been put on the factors that influence the potential biomass availability for energy purposes rather than give exact numbers. Six biomass resource categories for energy are identified: energy crops on surplus cropland, energy crops on degraded land, agricultural residues, forest residues, animal manure and organic wastes. Furthermore, specific attention is paid to the competing biomass use for material. The analysis makes use of a wide variety of existing studies on all separate categories. The main conclusion of the study is that the range of the global potential of primary biomass (in about 50 years) is very broad quantified at 33−1135 EJy −1 . Energy crops from surplus agricultural land have the largest potential contribution (0– 988 EJy −1 ) . Crucial factors determining biomass availability for energy are: (1) The future demand for food, determined by the population growth and the future diet; (2) The type of food production systems that can be adopted world-wide over the next 50 years; (3) Productivity of forest and energy crops; (4) The (increased) use of bio-materials; (5) Availability of degraded land; (6) Competing land use types, e.g. surplus agricultural land used for reforestation. It is therefore not “a given” that biomass for energy can become available at a large-scale. Furthermore, it is shown that policies aiming for the energy supply from biomass should take the factors like food production system developments into account in comprehensive development schemes.
673 citations
••
TL;DR: In this phase 2, multicenter, double‐blind, placebo‐controlled, multiple‐ascending‐dose trial of inclisiran administered as a subcutaneous injection in patients at high risk for cardiovascular disease who had elevated LDL cholesterol levels, inclisIRan was found to lower PCSK9 and LDL cholesterol Levels among patients athigh cardiovascular risk.
Abstract: BackgroundIn a previous study, a single injection of inclisiran, a chemically synthesized small interfering RNA designed to target PCSK9 messenger RNA, was found to produce sustained reductions in low-density lipoprotein (LDL) cholesterol levels over the course of 84 days in healthy volunteers. MethodsWe conducted a phase 2, multicenter, double-blind, placebo-controlled, multiple-ascending-dose trial of inclisiran administered as a subcutaneous injection in patients at high risk for cardiovascular disease who had elevated LDL cholesterol levels. Patients were randomly assigned to receive a single dose of placebo or 200, 300, or 500 mg of inclisiran or two doses (at days 1 and 90) of placebo or 100, 200, or 300 mg of inclisiran. The primary end point was the change from baseline in LDL cholesterol level at 180 days. Safety data were available through day 210, and data on LDL cholesterol and proprotein convertase subtilisin–kexin type 9 (PCSK9) levels were available through day 240. ResultsA total of 501 pa...
672 citations
••
Queen Mary University of London1, Utrecht University2, Trinity College, Dublin3, University of Groningen4, University of Oxford5, Wellcome Trust Sanger Institute6, University of Leeds7, Imperial College London8, University of Sheffield9, VU University Amsterdam10, Leiden University11, National University of Ireland12, University of London13, University of Bristol14
TL;DR: This extensive genome-wide association follow-up study has identified additional celiac disease risk variants in relevant biological pathways and identified seven previously unknown risk regions.
Abstract: Our genome-wide association study of celiac disease previously identified risk variants in the IL2-IL21 region. To identify additional risk variants, we genotyped 1,020 of the most strongly associated non-HLA markers in an additional 1,643 cases and 3,406 controls. Through joint analysis including the genome-wide association study data (767 cases, 1,422 controls), we identified seven previously unknown risk regions (P < 5 x 10(-7)). Six regions harbor genes controlling immune responses, including CCR3, IL12A, IL18RAP, RGS1, SH2B3 (nsSNP rs3184504) and TAGAP. Whole-blood IL18RAP mRNA expression correlated with IL18RAP genotype. Type 1 diabetes and celiac disease share HLA-DQ, IL2-IL21, CCR3 and SH2B3 risk regions. Thus, this extensive genome-wide association follow-up study has identified additional celiac disease risk variants in relevant biological pathways.
671 citations
Authors
Showing all 58756 results
Name | H-index | Papers | Citations |
---|---|---|---|
Ronald C. Kessler | 274 | 1332 | 328983 |
Albert Hofman | 267 | 2530 | 321405 |
Douglas G. Altman | 253 | 1001 | 680344 |
Hans Clevers | 199 | 793 | 169673 |
Craig B. Thompson | 195 | 557 | 173172 |
Patrick W. Serruys | 186 | 2427 | 173210 |
Ruedi Aebersold | 182 | 879 | 141881 |
Dennis S. Charney | 179 | 802 | 122408 |
Kenneth S. Kendler | 177 | 1327 | 142251 |
Jean Louis Vincent | 161 | 1667 | 163721 |
Vilmundur Gudnason | 159 | 837 | 123802 |
Monique M.B. Breteler | 159 | 546 | 93762 |
Lex M. Bouter | 158 | 767 | 103034 |
Elio Riboli | 158 | 1136 | 110499 |
Roy F. Baumeister | 157 | 650 | 132987 |